GENSIGHT BIOLOGICS Stock Went Down By Over 9% So Far On Monday
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) fell 9.45% to €0.66 at 11:51 EST on Monday, after two successive sessions in a row of losses. CAC 40 is dropping 0.24% to €7,559.03, following the last session’s upward trend. This seems, so far, a somewhat down trend exchanging session today. About GENSIGHT BIOLOGICS GenSight…